Cargando…

Productivity and quality improvement for a symmetric bispecific antibody through the application of intensified perfusion cell culture

BACKGROUND: Aggregation, fragmentation, and low yield are issues frequently found during the cell culture process of bispecific antibodies (bsAbs), whose inherent complexity likely plays a role in causing these issues. METHODS: In this study, we made a head-to-head comparison between fed-batch cell...

Descripción completa

Detalles Bibliográficos
Autores principales: Qin, Yongjun, Ma, Rongmei, Li, Yang, Li, Yifeng, Chen, Gong, Zhou, Weichang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9199187/
https://www.ncbi.nlm.nih.gov/pubmed/35719210
http://dx.doi.org/10.1093/abt/tbac009
_version_ 1784727798284288000
author Qin, Yongjun
Ma, Rongmei
Li, Yang
Li, Yifeng
Chen, Gong
Zhou, Weichang
author_facet Qin, Yongjun
Ma, Rongmei
Li, Yang
Li, Yifeng
Chen, Gong
Zhou, Weichang
author_sort Qin, Yongjun
collection PubMed
description BACKGROUND: Aggregation, fragmentation, and low yield are issues frequently found during the cell culture process of bispecific antibodies (bsAbs), whose inherent complexity likely plays a role in causing these issues. METHODS: In this study, we made a head-to-head comparison between fed-batch cell culture and intensified perfusion cell culture with a symmetric bsAb case. RESULTS: In comparison with the fed-batch culture, a 6.6-fold improvement in integrated viable cell density and a 10.9-fold improvement in volumetric productivity were achieved with the intensified perfusion mode. In addition, a significant decrease in aggregation and fragmentation was observed with the intensified perfusion cell culture. Furthermore, product homogeneity was improved, which was reflected by the increased percentage of capillary isoelectric focusing main group. The quality improvement with intensified perfusion cell culture can be attributed to the shortened product retention in the bioreactor. CONCLUSIONS: These findings suggest that intensified perfusion cell culture could be a better choice than traditional fed-batch especially for complex molecules like bsAbs. As this is a single case report, future studies on other cases are needed to further confirm the general applicability of this strategy.
format Online
Article
Text
id pubmed-9199187
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-91991872022-06-16 Productivity and quality improvement for a symmetric bispecific antibody through the application of intensified perfusion cell culture Qin, Yongjun Ma, Rongmei Li, Yang Li, Yifeng Chen, Gong Zhou, Weichang Antib Ther Original Research Article BACKGROUND: Aggregation, fragmentation, and low yield are issues frequently found during the cell culture process of bispecific antibodies (bsAbs), whose inherent complexity likely plays a role in causing these issues. METHODS: In this study, we made a head-to-head comparison between fed-batch cell culture and intensified perfusion cell culture with a symmetric bsAb case. RESULTS: In comparison with the fed-batch culture, a 6.6-fold improvement in integrated viable cell density and a 10.9-fold improvement in volumetric productivity were achieved with the intensified perfusion mode. In addition, a significant decrease in aggregation and fragmentation was observed with the intensified perfusion cell culture. Furthermore, product homogeneity was improved, which was reflected by the increased percentage of capillary isoelectric focusing main group. The quality improvement with intensified perfusion cell culture can be attributed to the shortened product retention in the bioreactor. CONCLUSIONS: These findings suggest that intensified perfusion cell culture could be a better choice than traditional fed-batch especially for complex molecules like bsAbs. As this is a single case report, future studies on other cases are needed to further confirm the general applicability of this strategy. Oxford University Press 2022-05-03 /pmc/articles/PMC9199187/ /pubmed/35719210 http://dx.doi.org/10.1093/abt/tbac009 Text en © The Author(s) 2022. Published by Oxford University Press on behalf of Antibody Therapeutics. All rights reserved. For Permissions, please email: journals.permissions@oup.com https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Original Research Article
Qin, Yongjun
Ma, Rongmei
Li, Yang
Li, Yifeng
Chen, Gong
Zhou, Weichang
Productivity and quality improvement for a symmetric bispecific antibody through the application of intensified perfusion cell culture
title Productivity and quality improvement for a symmetric bispecific antibody through the application of intensified perfusion cell culture
title_full Productivity and quality improvement for a symmetric bispecific antibody through the application of intensified perfusion cell culture
title_fullStr Productivity and quality improvement for a symmetric bispecific antibody through the application of intensified perfusion cell culture
title_full_unstemmed Productivity and quality improvement for a symmetric bispecific antibody through the application of intensified perfusion cell culture
title_short Productivity and quality improvement for a symmetric bispecific antibody through the application of intensified perfusion cell culture
title_sort productivity and quality improvement for a symmetric bispecific antibody through the application of intensified perfusion cell culture
topic Original Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9199187/
https://www.ncbi.nlm.nih.gov/pubmed/35719210
http://dx.doi.org/10.1093/abt/tbac009
work_keys_str_mv AT qinyongjun productivityandqualityimprovementforasymmetricbispecificantibodythroughtheapplicationofintensifiedperfusioncellculture
AT marongmei productivityandqualityimprovementforasymmetricbispecificantibodythroughtheapplicationofintensifiedperfusioncellculture
AT liyang productivityandqualityimprovementforasymmetricbispecificantibodythroughtheapplicationofintensifiedperfusioncellculture
AT liyifeng productivityandqualityimprovementforasymmetricbispecificantibodythroughtheapplicationofintensifiedperfusioncellculture
AT chengong productivityandqualityimprovementforasymmetricbispecificantibodythroughtheapplicationofintensifiedperfusioncellculture
AT zhouweichang productivityandqualityimprovementforasymmetricbispecificantibodythroughtheapplicationofintensifiedperfusioncellculture